Compare STE & NLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STE | NLY |
|---|---|---|
| Founded | 1985 | 1996 |
| Country | United States | United States |
| Employees | 3700 | N/A |
| Industry | Industrial Specialties | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.6B | 17.4B |
| IPO Year | 2018 | 1997 |
| Metric | STE | NLY |
|---|---|---|
| Price | $237.43 | $23.45 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 11 |
| Target Price | ★ $275.20 | $23.82 |
| AVG Volume (30 Days) | 715.0K | ★ 7.2M |
| Earning Date | 05-11-2026 | 04-21-2026 |
| Dividend Yield | 1.19% | ★ 12.42% |
| EPS Growth | 27.90 | ★ 80.25 |
| EPS | ★ 7.93 | 1.40 |
| Revenue | ★ $5,935,900,000.00 | N/A |
| Revenue This Year | $9.88 | $188.83 |
| Revenue Next Year | $6.32 | $2.40 |
| P/E Ratio | $29.88 | ★ $16.96 |
| Revenue Growth | ★ 8.73 | N/A |
| 52 Week Low | $195.14 | $20.00 |
| 52 Week High | $269.44 | $24.52 |
| Indicator | STE | NLY |
|---|---|---|
| Relative Strength Index (RSI) | 60.82 | 65.03 |
| Support Level | $216.22 | $22.20 |
| Resistance Level | $238.53 | $24.43 |
| Average True Range (ATR) | 5.73 | 0.30 |
| MACD | -0.47 | 0.07 |
| Stochastic Oscillator | 82.05 | 85.62 |
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Steris also sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 20% from Applied Sterilization Technologies, or AST, and 10% from life sciences services after the divestment of its dental products business.
Annaly Capital Management Inc is an American mortgage real estate investment trust. Its business objective is to generate net income for distribution to its stockholders and optimize its returns through prudent management of its diversified investment strategies. The company's reportable operating segments are: the Agency segment, which invests in Agency mortgage-backed securities collateralized by residential mortgages; the Residential Credit segment, which invests in non-Agency residential whole loans and securitized products within the residential and commercial markets; the Mortgage Servicing Rights segment; and Corporate & Other. Maximum revenue for the company is generated from its Agency segment.